Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis

Ann Allergy Asthma Immunol. 2015 Sep;115(3):250-1. doi: 10.1016/j.anai.2015.06.014. Epub 2015 Jul 7.

Authors

Martin Oman Evans 2nd¹, Michael J Morris², Christopher Albert Coop², Sara Ellen Evans³

Affiliations

¹ San Antonio Military Medical Center, San Antonio, Texas. Electronic address: [email protected].
² San Antonio Military Medical Center, San Antonio, Texas.
³ College of Osteopathic Medicine of the Pacific-Northwest, Lebanon, Oregon.

PMID: 26162570
DOI: 10.1016/j.anai.2015.06.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Allergic Agents / therapeutic use*
Anti-Asthmatic Agents / adverse effects
Anti-Asthmatic Agents / therapeutic use*
Aspergillosis, Allergic Bronchopulmonary / drug therapy*
Aspergillosis, Allergic Bronchopulmonary / immunology
Aspergillus fumigatus / immunology
Asthma / drug therapy
Female
Humans
Omalizumab / adverse effects
Omalizumab / therapeutic use*
Treatment Outcome

Substances

Anti-Allergic Agents
Anti-Asthmatic Agents
Omalizumab